DISCLOSURES OF RELATIONSHIPS In order for the College to most effectively further its mission and to otherwise maintain its excellent reputation in the medical community and with the public, it is important that confidence in the College’s integrity be maintained. The cornerstone of the ACR’s Disclosure Policy is disclosure of actual and potential conflicts so that they can be evaluated by the College in order to avoid undue influence of potential conflicts. The purpose of the ACR’s Disclosure Policy is identification of relationships which may pose actual or potential conflicts. These actual or potential conflicts can then be evaluated by the College so that adjustments can be made that will avoid any undue influence. This policy is based on the principle that, in many cases, full disclosure of the actual or potentially conflicting relationship will of itself suffice to protect the integrity of the College and its interests.

Participants

Role

Kenneth Saag

QOC; Chair

Brian Feldman Liana Fraenkel

QOC member QOC member

Yvonne Golightly L. Douglas Graham

QOC member QOC member

Iain McInnes

QOC member

Seoyoung Kim

QOC member

Rodolfo Molina

QOC member/ Guidelines Chair QOC member, Board liaison

Tuhina Neogi Eric Newman Carol Oatis

QOC member QOC member QOC member

Deepak Rao

QOC member

Daniel Solomon

QOC member

Ted Mikuls

Primary employer

Sources of personal income to include speakers bureau, honoraria, royalties, expert witness fees, advisory boards, Intellectual Property to or any other sources of income include copyrights, (excludes salary from primary patents, or licenses employer)

University of Alabama at Birmingham

Abbott; Amgen; Antares; Ardea; BioCryst; BMS; Crescendo; Eli Lilly; Horizon; Iroko; Jansse; Merck; Regeneron; Roche

University of Nebraska; Omaha VA Arthritis Association Boston University School of Medicine Geisinger Health System Arcadia University Brigham and Women's Hospital Brigham and Women's Hospital

Activities with other organizations

Family or other relations

NA

NA

NA

NA NA

AHRQ; NIH/NIAMS; NIH; Amgen; Merck; Takeda; Ardea; Bayer; Baxter; Rare Disease Foundation VA; NIAMS; AF; RRF

NOF; Current Rheumatology Reports; Annals of Internal Medicine; ASBMR

NA NA

NA NA

The Arthritis Society; CRA NA NA NA

NA NA

AF; NIH/NCATS NA

NA NA

NA NA

NA NA

NA NA

NA

ARUK; MRC; BMSL Roche, Pfizer NA

NA

NA

NA

NA

NA

NIH/ NIAMS; Pfizer; Takeda

NA

NA

NA

NA

NA

NA

NIH/NIAMS; Genentech/Roche; ACR RRF; NIH/NIAMS NA

NA

NA

NA

Texas Medical Board

NA

NA

NA

NA

NA

NA

NA Kinetix Group NA

NA NA NA

NIAMS; NIA RRF NA

NA NA NA

NA NA NA

NA NA NA

NA NA NA

NA UpToDate; American Orthopedics Association

NA

NIH

NA

NA

NA

NA

NA

NIH; Lilly; Forest; Amgen

NA

Roche

A&R

NA

The Hospital for Sick Children Novartis; Pfizer; BMS Yale University; VA NA ACR/ARHP; University of Nebraska Unviersity of North Carolina Medical Center Du Page Medical Group NA BMS; Pfizer; Abbott; NovoNoridisk; Roche; Grunenthal; Crescendo University of Glasgow Bioscience; Celgene Brigham & Women's Hospital

Research Grants/Contracts

Investments to include medical industry and non- Organizational medical industry Benefit

NA

Participants

Role

Primary employer

Astellas Pharma Glbal Development, Inc.; Crescendo Bioscience; Data Centrum Communications, Inc.; Elsevier; Fourteen22 Inc.; Informa UK Limited; KAI Research, Inc.; NCME; Oxford University Press; Publication Connexion LLC; Pfizer, Inc; UCB; University of Alabama; University of Chicago; UpToDate

Research Grants/Contracts

Investments to include medical industry and non- Organizational medical industry Benefit

Activities with other organizations

Family or other relations

ARD; Seminars in Arthritis & Rheumatism; The Journal of Clinical Abbott Rheumatology and Laboratories; Janssen RND, LLC; Musculoskeletal; Pfizer Inc; Abbott; Spondyloarthritis BMS; Genentech; Research and Treatment Network; NA CSMC Arthritis Foundation; NA AJRR Spouse (stock)

NA

ACR; ACR/EULAR; Amgen; Biogen; Cephalon; Driskill Foundation; Dynavax; Genentech; HGS; Lilly; NIH; Pfizer, SAA; Teva; UCB

NA

NACH

NA

CDC; DC Department of Health

NA

NA

NA

NIH/NIAMS K23; DHHS ASPE; Lupus Clinical Trials Consortium NA

NA

NA

NA

Guidelines Subcommittee member UCLA

NA

NA

NA

NA

NA

NA

NA

Guidelines Subcommittee member St. Joseph Healthcare

NA

NA

NA

NA

NA

NA

NA

Guidelines Harvard Medical School Subcommittee member

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

Takeda; Savient; NIAMS; AHRQ; VA NA

NA

NA OMERACT; JCR; BMC MSD; VA Field Advsory committee

NA

NA

Sanofi; Janssen; Novartis; UCB; Genentech; Genentech/Roche; Centocor; Pfizer; Roche;

NA

NA

NA

Michael Weisman

QOC member

Patience White

QOC member

Cedars-Sinai Medical Center George Washington University

Jinoos Yazdany Jennifer Grossman (disclosure forthcoming)

QOC member

University of California San Francisco

Donald Krause Elena Massarotti (disclosure forthcoming) Joan McTigue (disclosure forthcoming)

Sources of personal income to include speakers bureau, honoraria, royalties, expert witness fees, advisory boards, Intellectual Property to or any other sources of income include copyrights, (excludes salary from primary patents, or licenses employer)

Jasvinder Singh

University of Florida/VA Med Guidelines Center NA Subcommittee member Birmingham VA Med Ctr; University of Alabama at Savient; Novartis; Takeda; Ardea; Guidelines Allergan; Regeneron; URL Subcommittee member Birmingham

Brandon L. Young

Guidelines North Mississippi Medical Subcommittee member Clinics

Genentech

NA

Participants

Role

Primary employer

Sarah Ringold

Principal Investigator

Pam Weiss

Principal Investigator

Seattle Children's Hospital Children's Hospital Philadelphia

Timothy Beukelman

Core Expert Panel

Esi Morgan DeWitt

Sources of personal income to include speakers bureau, honoraria, royalties, expert witness fees, advisory boards, Intellectual Property to or any other sources of income include copyrights, (excludes salary from primary patents, or licenses employer) NA Puerto Rico Rheumatism society Genentech; McKesson Health Solutions; Novartis

Research Grants/Contracts

Investments to include medical industry and non- Organizational medical industry Benefit

Activities with other organizations

Family or other relations

NA

AHRQ; ACR REF

NA

NA

NA

NA

NA

NIH ; ACR Pfizer; AHRQ; NIH/NCRR; NIH/NIAMS/Cincinnati Children's NIH/NIAMS; CERTS/AHRQ; Arthritis Foundation NIAMS/NIH; Arthritis Foundation Rhematology Research Foundation; Arthritis Foundation; NIAMS; Roche

NA

NA

NA

NA

NA

NA Childhood Arthritis Rehumatology Research A.

NA

NA

PR-COIN

NA

NA

NA

CARRA

NA

NA

NA

Arthritis Foundation

NA

Novartis

NA

NA

NA

NA

Core Expert Panel

University of Alabama at Birmingham Cincinnati Children's Hospital Medical Center NA

NA

Norman Ilowite

Core Expert Panel

Montefoire Medical Center

Novartis; Janssen

NA

Yukiko Kimura

Core Expert Panel

Hackensack UMC

Novartis

NA

Ronald Laxer

Core Expert Panel

Daniel Lovell

Core Expert Panel

NIH

NA

NA

NA

NA

Peter Nigrovic

Core Expert Panel

The Hospital for Sick Children Elsevier Publisher NA Amgen; UBC; Centocor, Inc.; HoffmanLa Roche Inc.; Novartis; UBC; A&R Editorial Board; Astra-Zeneca Pharm; NA Cincinnati Children's Hospital Forest Research. American Acad of Pediatrics; Alkermes Inc; Int J Advances in Rheum; Brigham & Women's Hosp.; UptoDate; Novartis NA Boston Children's Hosp.

NIH/NIAID; NIH/NIAMS; ANRF; Baxter Foundation

NA

NA

NA

NA

Angela Robinson

Core Expert Panel

University Hospital Medical Group

NA

NA

NIH; Rainbow Babies Children's Hospital; Arthritis Foundation NA

NA

NA

NA

Richard Vehe

Core Expert Panel

University of Minnesota

American Board of Pediatrics

NA

NIH/Arthritis Foundation; NIH

NA

NA

NA

Sheila Angeles-Han

Task Force Panel

NA

NA

Task Force Panel

NA

Robert A. Colbert

Task Force Panel NIH / NIAMS Patient Rep/ Task Force Panel Self Employed

American Academy of Pediatrics; ACR Amer. Board of Pediatrics; March of Dimes

NA

NIH

NA

NA NA Children's Mercy AAP; ACR; MWSPR; Hospital ASCPT Spond. Assoc. Amer.; NA SPARTAN

NA

Mara L Becker

ACR/RRF/AF NA RRF; Arthritis Foundation; BMS; NIAMS P01 NA

NA Sibling (Employee)

NA

NA

NA

NA

NA

Child (patient)

Vincent Del Gazio

Emory University; Children's Healthcare of Atlanta Children's Mercy Hospitals and Clinics

NA

NA

Friends of CARRA

NA

Participants

Role

Primary employer

Pavla Dolezalova

Task Force Panel

Charles University; VFN

Polly Ferguson

Task Force Panel

Chris Feudtner

Task Force Panel

University of Iowa Children's Hospital Philadelphia

Sources of personal income to include speakers bureau, honoraria, royalties, expert witness fees, advisory boards, Intellectual Property to or any other sources of income include copyrights, (excludes salary from primary patents, or licenses employer)

Biovitrum; BMS; Novartis Pharm. Corp; Pfizer NA Northwestern University; University of Utah NA Buckley & Theorm; Pediatric Grand Rounds on Medical Etnics NA

Investments to include medical industry and non- Organizational medical industry Benefit

Activities with other organizations

Roche; Pfizer; Italfarmaco

NA

NA

European Union Executive Agency HEALTH and consumers; European Union FP7 NA

NIH/NIAMS; MIH/NICHD

NA

NA

NA

NA

NIH; AHRQ; Mayday

NA

NA

NA

NA

NA

Research Grants/Contracts

Family or other relations

NA

Roche; Novartis; Pfizer; Abbott; BMS NA

NA BMS; Janssen; Glaxo Smith & Kline; Novartis; Pfizer-Roche

NA

Pfizer; NIH

NA

NA

NA

NA

Alberto Martini

Task Force Panel

Murray Passo

Task Force Panel

Astrazeneca; Novartis; BMS; Glazo University of Genoa; IRCCS G. Smith & Kline; Boehringer Ingelheim; Novonordisk; MedImmune: Sanofi Gaslini Medical University of South Carolina Pfizer

Sampath Prahalad

Task Force Panel

Emory University; Children's Healthcare of Atlanta

NA

NA

NIH; Arthritis Foundation

NA

NA

NA

NA

Lyn Punaro

Task Force Panel

University Texas Southwestern Medical Center NA

NA

Carranet

NA

NA

ABP

NA

NA

Ontario Ministry of Health; Canadian Initiative for Outcomes in Rheumatology Care; The Hospital for Sick Childre, Pediatric Consultants Education Research Grants Committee; Bourse en pedagogie medicale, CHU St. Justine; PSI Foundation Medical Education Research and Development Grant; HoffmanLa Roche; Novartis Pharmaceuticals Canada Inc.; Roche Pharmaceuticals NA

NA

Ontario Rheumatology Association

NA

NA

RRF ACR; NIH

NA

NA

NA

Rayfel Schneider

Task Force Panel

David Sherry

Task Force Panel

Novartis Advisory Board; Hoffman-La The Hospital for Sick Children Roches; Medscape University of Pennsylvania; Children's Hospital Martin, Magnuson, McCarthy & Philadelphia Kenney; Hoffman, Hart. Wagner

NA

Participants

Role

Primary employer

Sources of personal income to include speakers bureau, honoraria, royalties, expert witness fees, advisory boards, Intellectual Property to or any other sources of income include copyrights, (excludes salary from primary patents, or licenses employer)

Richard Vehe

Task Force Panel

University of Minnesota

American Board of Pediatrics

Carol Wallace

Task Force Panel

Children’s University Medical ACR; Danish Pediatric Rheumatology Group Society; Genentech; Novartis

Activities with other organizations

Family or other relations

NA

Research Grants/Contracts NIH NIAMS; Seattle Children's; NIH/HHSN

Investments to include medical industry and non- Organizational medical industry Benefit NA

NA

NA

NA

NA

NIAMS; Pfizer; Amgen; NINR

NA

NA

NA

NA